A detailed history of Petredis Investment Advisors LLC transactions in Danaher Corp stock. As of the latest transaction made, Petredis Investment Advisors LLC holds 10,736 shares of DHR stock, worth $2.48 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
10,736
Previous 10,702 0.32%
Holding current value
$2.48 Million
Previous $2.67 Billion 11.63%
% of portfolio
0.32%
Previous 0.3%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$239.25 - $280.76 $8,134 - $9,545
34 Added 0.32%
10,736 $2.98 Billion
Q2 2024

Jul 16, 2024

SELL
$235.51 - $267.98 $1,884 - $2,143
-8 Reduced 0.07%
10,702 $2.67 Billion
Q1 2024

Apr 25, 2024

BUY
$224.58 - $256.19 $45,814 - $52,262
204 Added 1.94%
10,710 $2.67 Billion
Q4 2023

May 20, 2024

SELL
$185.1 - $233.13 $59,232 - $74,601
-320 Reduced 2.98%
10,416 $2.41 Billion
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $42,573 - $53,619
-230 Reduced 2.14%
10,506 $2.43 Billion
Q3 2023

May 20, 2024

BUY
$233.08 - $265.59 $5,593 - $6,374
24 Added 0.22%
10,736 $2.66 Billion
Q3 2023

Nov 01, 2023

BUY
$233.08 - $265.59 $5,593 - $6,374
24 Added 0.22%
10,736 $2.66 Billion
Q2 2023

May 20, 2024

SELL
$224.99 - $256.14 $899 - $1,024
-4 Reduced 0.04%
10,712 $2.57 Billion
Q2 2023

Aug 07, 2023

SELL
$224.99 - $256.14 $899 - $1,024
-4 Reduced 0.04%
10,712 $2.57 Billion
Q1 2023

May 20, 2024

BUY
$239.75 - $277.0 $31,407 - $36,287
131 Added 1.24%
10,716 $2.7 Billion
Q1 2023

May 03, 2023

BUY
$239.75 - $277.0 $31,407 - $36,287
131 Added 1.24%
10,716 $2.7 Billion
Q4 2022

May 20, 2024

SELL
$241.42 - $282.29 $30,177 - $35,286
-125 Reduced 1.17%
10,585 $2.81 Billion
Q4 2022

Feb 06, 2023

BUY
$241.42 - $282.29 $2.56 Million - $2.99 Million
10,585 New
10,585 $2.81 Billion

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Petredis Investment Advisors LLC Portfolio

Follow Petredis Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petredis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Petredis Investment Advisors LLC with notifications on news.